Peripheral Endovascular Revascularization Trials: High Noon for Uniform Reporting Standards

References

• Norgren L., Hiatt W. R., Dormandy J. A., Nehler M. R., Harris K. A., Fowkes F. G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg, 2007, 45: S5–S67.
   Google Scholar
• Dotter C. T., Judkins M. P. Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of Its Application. Circulation 1964, 30: 654670.
   Google Scholar
• Adam D. J., Beard J. D., Cleveland T., Bell J., Bradbury A. W., Forbes J. F. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet, 2005, 366: 1925–1934.
   Google Scholar
• Anderson P. L., Gelijns A., Moskowitz A., Arons R., Gupta L., Weinberg A. et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980–2000. J Vasc Surg, 2004, 39: 1200–1208.
   Google Scholar
• Sackett D. L., Rosenberg W. M., Gray J. A., Haynes R. B., Richardson W. S. Evidence based medicine: what it is and what it isn’t. Clin Orthop Relat Res, 2007, 455: 3–5.
   Google Scholar
• Diehm N., Baumgartner I., Jaff M., Do D. D., Minar E., Schmidli J. et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J, 2007, 28: 798–805.
   Google Scholar
• Rutherford R. B., Baker J. D., Ernst C., Johnston K. W., Porter J. M., Ahn S. et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997, 26: 517–538.
   Google Scholar
• Rutherford R. B., Flanigan D. P., Gupta S. K., Johnston K. W., Karmondy A., Whittemore A. D. et al. Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1986, 4: 80–94.
   Google Scholar
• Cutlip D. E., Windecker S., Mehran R., Boam A., Cohen D. J., van Es G. A. et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 2007, 115: 23442351.
   Google Scholar
• Diehm N., Pattynama P. M., Jaff M., Cremonesi A., Becker G. J., Hopkins L. N. et al. Clinical endpoints in peripheral endovascular revascularization trials: A case for standardized definitions. Eur J Endovasc Vasc Surgery, 2008, in press.
   Google Scholar
• Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W. et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006, 354: 1879–1888.
   Google Scholar
• Schillinger M., Sabeti S., Dick P., Amighi J., Mlekusch W., Schlager O. et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation, 2007, 115: 2745–2749.
   Google Scholar
• Krankenberg H., Schlüter M., Steinkamp H. J., Burgelin K., Scheinert D., Schulte K. L. et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation, 2007, 116: 285–292.
   Google Scholar
• Katzen B. In: International Symposium of Endovascular Therapy, 2008, Miami, FL, USA, 2008.
   Google Scholar
• Tepe G., Zeller T., Albrecht T., Heller S., Schwarzwalder U., Beregi J. P. et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med, 2008, 358: 689–699.
   Google Scholar
• Diehm N., Baumgartner I., Juni P. Local paclitaxel delivery in peripheral vascular disease. N Engl J Med, 2008, 358: 2406–2407, author reply 2407.
   Google Scholar
• Dorros G., Jaff M. R., Dorros A. M., Mathiak L. M., He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation, 2001, 104: 2057–2062.
   Google Scholar
• Faglia E., Mantero M., Caminiti M., CaravaggI C., De Giglio R., Pritelli C. et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med, 2002, 252: 225–232.
   Google Scholar
• Bosiers M., Deloose K., Verbist J., Peeters P. Percutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg (Torino), 2006, 47: 171–176.
   Google Scholar
• Feiring A. J., Wesolowski A. A., Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol, 2004, 44: 2307–2314.
   Google Scholar
• Brosi P., Baumgartner I., Silvestro A., Do D. D., Mahler F., Triller J. et al. Below-the-knee angioplasty in patients with endstage renal disease. J Endovasc Ther, 2005, 12: 704–713.
   Google Scholar
• Siablis D., Karnabatidis D., Katsanos K., Kagadis G. C., Kraniotis P., Diamantopoulos A. et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther, 2007, 14: 241–250.
   Google Scholar
• Dick F., Diehm N., Galimanis A., Husmann M., Schmidli J., Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg, 2007, 45: 751–761.
   Google Scholar
• Brosi P., Dick F., Do D. D., Schmidli J., Baumgartner I., Diehm N. Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. J Vasc Surg, 2007, 46: 1198–1207.
   Google Scholar
• Graziani L., Silvestro A., Bertone V., Manara E., Andreini R., Sígala A. et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg, 2007, 33: 453–460.
   Google Scholar